The benefit of combining docetaxel to androgen deprivation therapy in localized and metastatic castration-sensitive prostate cancer as predicted by ERG status: An analysis of two GETUG phase III trials
Rajpar, Shanna, Carmel, Alexandra, Merabet, Zahira, Vielh, Philippe, Foulon, Stéphanie, Lesaunier, Francois, Delva, Remy, Rolland, Frederic, Priou, Frank, Ferrero, Jean-Marc, Houede, Nadine, Mourey, Loic, Theodore, Christine, Krakowski, Ivan, Faivre, Laura, Habibian, Muriel, Culine, Stephane, Chauchereau, Anne, Gravis, Gwenaelle, Fizazi, Karim
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article